Many patients are looking forward to trying the new inhaled insulin, Exubera
March 2006
Many patients are looking forward to trying the new inhaled insulin, Exubera, when it comes out later this summer.
It will be an alternative to short-acting mealtime insulin.
It has a fast onset like Humalog or Novolog...but a longer duration like regular insulin (Humulin, etc).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote